For adults aged 60 years or older, respiratory syncytial virus (RSV) vaccination is effective for preventing associated hospitalizations and emergency department encounters.

I t’s not just officially cold and flu season, it’s RSV season. RSV, which stands for respiratory syncytial virus, is a highly contagious illness that affects people of all ag ...

Big Data, Real World, Multi-State Study Finds RSV Vaccine Highly Effective in Protecting Older Adults Against Severe Disease, Hospitalization and Death Oct. 17, 2024 — This multi-state study is ...

WAUSAU, Wis. (WSAW) --- Doctors recommend that people learn about the RSV vaccine as cold and flu season approaches Wisconsin. RSV, or Respiratory Syncytial Virus, is a common contagious virus that ...

Almost all children will get RSV during their first two years, but each year up to 80,000 children are hospitalized due to it ...

The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...

Canada's vaccine advisers recommend RSV shots for infants "The news Ontario has access to new RSV-prevention products is very, very exciting and should be top of mind for any family with a young ...

The local Infectious Disease team at Heywood Healthcare advises greater Gardner residents to get influenza, the updated COVID-19, and if eligible the RSV vaccines as soon as you can. Everyone ...

Vaxxas’ worldwide license from the NIH enables the company to create the first needle-free, room-temperature stable RSV vaccine to enter clinical studies. The next-generation DS2 RSV vaccine ...

“By expanding the number of children eligible under the RSV program and ensuring people have access to convenient, publicly funded flu and COVID-19 vaccines, our government is making it easier for ...

Yes, although it is very rare, it is possible for respiratory syncytial virus (RSV) to cause meningitis. Specifically, it can cause viral meningitis. Viral meningitis is the most common type of ...

The U.S. Food and Drug Administration (FDA) has approved Abrysvo, a vaccine that protects against lung infections caused by the respiratory syncytial virus — commonly known as RSV — for adults as ...